Enzo Biochem, Inc.
SPHINGOSINE KINASE TYPE 1 INHIBITORS AND USES THEREOF
Last updated:
Abstract:
Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).
Status:
Application
Type:
Utility
Filling date:
17 Sep 2019
Issue date:
5 Mar 2020